UMIN-CTR Clinical Trial

Basic information
Public title	Analysis of the relationship between collagen peptide metabolism and e-sports
Acronym	Collagen peptid & eSports
Scientific Title	Analysis of the relationship between collagen peptide metabolism and e-sports
Scientific Title:Acronym	Collagen peptid & eSports
Region	Japan

Condition
Condition	Movement disorder
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	Since specific parts such as wrists, neck, and back are frequently used in training for e-sports activities, it is considered that there are metabolites of collagen peptide specifically produced by these parts. Therefore, the applicants hypothesized that there may be specific components of e-sports activity in blood and urine. The purpose of this study is to elucidate the metabolites of collagen peptide specific to e-sports, targeting university student players of e-sports.
Basic objectives2	Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Urine and blood metabolites (metabolomics analysis)
Key secondary outcomes

Base
Study type	Interventional

Study design
Basic design	Cross-over
Randomization	Non-randomized
Randomization unit
Blinding	Open -no one is blinded
Control	No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Prevention
Type of intervention	Food Other
Interventions/Control_1	Collagen peptide 10 g single time
Interventions/Control_2	eSports 3-4 hours
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	30 years-old >=
Gender	Male
Key inclusion criteria	Those who practice eSports on a daily
Key exclusion criteria	People who have food allergies to meat and gelatin Women
Target sample size	30

Research contact person
Name of lead principal investigator	1st name Hiroshi Middle name Last name Mano
Organization	Josai University
Division name	Faculty of Pharmacy and Pharmaceutical Sciences
Zip code	350-0295
Address	Keyakidai 1-1, Sakado, Saitama
TEL	049-271-7246
Email	h-mano@josai.ac.jp

Public contact
Name of contact person	1st name Katsumata Middle name Last name Kimiko
Organization	Josai University
Division name	Experiment Center Office
Zip code	350-0295
Address	Keyakidai 1-1, Sakado, Saitama
TEL	049-271-7735
Homepage URL
Email	kkimiko@stf.josai.ac.jp

Sponsor
Institute	Josai University
Institute
Department

Funding Source
Organization	Josai University
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Josai University Life Science / Medical Research Ethics Review Board for Humans
Address	Keyakidai 1-1, Sakado, Saitama
Tel	049-271-7735
Email	kkimiko@stf.josai.ac.jp

Secondary IDs
Secondary IDs	YES
Study ID_1	2020-06A
Org. issuing International ID_1	Josai University
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2025 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Suspended
Date of protocol fixation	2020 Year 10 Month 09 Day
Date of IRB	2020 Year 10 Month 09 Day
Anticipated trial start date	2023 Year 04 Month 01 Day
Last follow-up date	2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2022 Year 07 Month 05 Day
Last modified on	2022 Year 07 Month 05 Day

Link to view the page
URL(English)	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054911